Insider Buying Fuels Optimism Amid a Quiet Stock‑Price Decline
Enact Holdings’ most recent 13‑F filing discloses that director Sheila Hooda purchased 162 deferred stock units on March 19, 2026, increasing her stake by approximately 30,700 shares. The transaction incurred no cash outlay, as the deferred‑unit structure vests a year after her director tenure concludes. While the company’s market price slipped 1.2 % during the week and 3 % for the month, the additional holdings signal confidence in Enact’s long‑term trajectory.
Market Context and Investor Interpretation
The buying activity occurs against a backdrop of an exceptionally bullish social‑media pulse—Buzz at 2,712 % and a perfect sentiment score of +100. This surge of positive chatter may be driving short‑term demand, but fundamental analysis remains pivotal. Enact’s price‑to‑earnings ratio sits at 8.99, and its year‑to‑date gain of 17 % positions the stock as relatively inexpensive compared to earnings.
Recent executive turnover, with CFO David Wang’s departure and Michael Huang’s appointment, introduces a degree of uncertainty. The insider purchase can be viewed as a hedge against this transition risk, suggesting that the incoming CFO will maintain or enhance operational performance.
Sheila Hooda: A Consistent Long‑Term Investor
Hooda’s trade history illustrates a disciplined, incremental acquisition of deferred units. Beginning with 30,543 shares in December 2025 and rising to 30,705 shares in September 2025, the pattern persisted with the March 19 purchase. All transactions were executed at zero cost, underscoring a belief in Enact’s future upside rather than short‑term speculation. Unlike other insiders who often sell or trade common stock, Hooda’s focus on deferred units signals a long‑term horizon, aligning her interests closely with the company’s strategic objectives.
Strategic Implications for Enact Holdings
With a robust insider buyback amid leadership change, Enact Holdings occupies an inflection point. The deferred‑unit purchases reinforce management’s confidence and may stabilize the share price during the CFO transition. For shareholders, the continued insider buying provides a subtle endorsement of Enact’s mortgage‑insurance business model, indicating that the company’s strategic direction—supported by its market capitalization and favorable P/E—remains solid.
Investors should monitor the new CFO’s early performance metrics and any subsequent insider activity for signals about Enact’s trajectory over the next quarter.
Summary of Insider Transactions (March 19, 2026)
| Owner | Transaction Type | Shares | Security |
|---|---|---|---|
| Hooda, Sheila | Buy | 162 | Deferred Stock Units |
| Gould, Brian (EVP & COO) | Buy | 11, 17, 21 | Restricted Stock Units |
| McMullen, James (Controller) | Buy | 5, 7, 8, 14, 9 | Restricted Stock Units |
| Gupta, Rohit (President & CEO) | Buy | 97, 158, 197 | Restricted Stock Units |
| Mitchell, Hardin (EVP, CFO & Treasurer) | Buy | 33, 53, 69 | Restricted Stock Units |
| FISK, John D. | Buy | 162 | Deferred Stock Units |
| Restrepo, Robert P. Jr. | Buy | 162 | Deferred Stock Units |
| Derstine, Michael (EVP & Chief Risk Officer) | Buy | 13, 21, 36 | Restricted Stock Units |
| Still, Debra | Buy | 162 | Deferred Stock Units |
| Thompson, Westley V. | Buy | 162 | Deferred Stock Units |
| Addesso, Dominic James | Buy | 281 | Deferred Stock Units |
| Addesso, Dominic James | Holding | 24,177; 20,650 | Deferred Stock Units |
| Stolove, Evan (EVP, Gen. Counsel & Secretary) | Buy | 13, 21, 26 | Restricted Stock Units |
| Bless, Michael A. | Buy | 139 | Deferred Stock Units |
| Mitchell, H. Elizabeth | Buy | 30 | Deferred Stock Units |
All prices per share are listed as “N/A” due to the zero‑cost nature of the deferred‑unit transactions.




